ClinicalTrials.gov 临床试验·· 20 天前AI 评分18
诺华伊马替尼IV期开放标签多中心滚动研究:评估既往获益患者的长期安全性
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
AI 导读
诺华开展一项IV期开放标签多中心滚动研究,评估伊马替尼在已完成既往诺华申办伊马替尼研究、且经研究者判断仍持续获益患者中的长期安全性。该研究为单臂扩展用药,未披露具体适应症及疗效终点数据。
来源:ClinicalTrials.gov 临床试验 · clinicaltrials.gov